The co-loaded liposomes possess the following advantages: 1) inhibit activation of HSCs, 2) reduce drug resistance of HCC by blocking the cross-talk between aHSCs and tumor cells, and 3) improve anti-tumor effect by HA/CD44- and GA/GA receptor-mediated drug internalization. Here, CD44 is linked to neoplasm.